These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 1581951)
21. [The efficacy of the ADTP-vaccine immunization of children with different courses of the vaccinal period]. Sliusar' LI; Romanenko TA; Dubil'er Zhi ; Panasenko LI; Litvinova TP Pediatriia; 1992; (10-12):22-5. PubMed ID: 1291954 [No Abstract] [Full Text] [Related]
22. Immunization responses in preterm infants who receive postnatal steroid treatment. Berrington J; Fenton A Pediatrics; 2004 Oct; 114(4):1127-8; author reply 1128-9. PubMed ID: 15466119 [No Abstract] [Full Text] [Related]
24. Vaccines: World Health Organization versus Federal Drug Administration recommended formula. Khalil MK; al-Mazrou YY; al-Ghamdi YS East Mediterr Health J; 2000 Jul; 6(4):644-51. PubMed ID: 11794070 [TBL] [Abstract][Full Text] [Related]
25. [The relationship of the intensity of antibody formation to the causative agents of diphtheria and tetanus to genetic markers in children vaccinated with adsorbed DPT]. Prilutskiĭ AS; Sokhin AA; Maĭlian EA; Koteneva GE; Lugovaia IuV Zh Mikrobiol Epidemiol Immunobiol; 1994; (2):89-92. PubMed ID: 8017136 [TBL] [Abstract][Full Text] [Related]
26. Diphtheria and tetanus toxoids and pertussis vaccine adsorbed (DTP): response to varying immunizing dosage and schedule. Barkin RM; Samuelson JS; Gotlin LP Dev Biol Stand; 1985; 61():297-307. PubMed ID: 2872117 [TBL] [Abstract][Full Text] [Related]
27. Definition of minimum standards for immunogenicity--potential problems of serological correlates--possible interference. Serological correlates for diphtheria-tetanus-whole cell pertussis vaccines. Heron I Biologicals; 1994 Dec; 22(4):389-90. PubMed ID: 7779366 [No Abstract] [Full Text] [Related]
28. Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine for the first four doses. Halperin SA; King J; Law B; Mills E; Willems P Clin Infect Dis; 1999 May; 28(5):995-1001. PubMed ID: 10452624 [TBL] [Abstract][Full Text] [Related]
29. [The evaluation of the efficacy of a first course of immunization against diphtheria and tetanus in children with kidney diseases]. Magarshak OO; Kostinov MP; Sergeeva TV; Kapitonova ME Zh Mikrobiol Epidemiol Immunobiol; 1999; (4):43-6. PubMed ID: 10852049 [TBL] [Abstract][Full Text] [Related]
30. Antibody level of New Zealand children immunized with the triple vaccine DTP (diphtheria-tetanus-pertussis). Lau RC Epidemiol Infect; 1988 Oct; 101(2):405-10. PubMed ID: 2903065 [TBL] [Abstract][Full Text] [Related]
31. Safety and immunogenicity of a Haemophilus influenzae type B polysaccharide-tetanus toxoid conjugate vaccine combined with diphtheria, tetanus and pertussis vaccines in Thai infants. Chotpitayasunondh T; Panpitpat C; Thisyakorn U; Furer E; Que JU; Hasler T; Cryz SJ Southeast Asian J Trop Med Public Health; 1997 Mar; 28(1):91-8. PubMed ID: 9322290 [TBL] [Abstract][Full Text] [Related]
33. Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine. Panpitpat C; Thisyakorn U; Chotpitayasunondh T; Fürer E; Que JU; Hasler T; Cryz SJ Bull World Health Organ; 2000; 78(3):364-71. PubMed ID: 10812736 [TBL] [Abstract][Full Text] [Related]
34. Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents. Pichichero ME; Blatter MM; Kennedy WA; Hedrick J; Descamps D; Friedland LR Pediatrics; 2006 Apr; 117(4):1084-93. PubMed ID: 16585302 [TBL] [Abstract][Full Text] [Related]
35. Combined diphtheria-tetanus-pertussis vaccine for tetanus-prone wound management in adults. Hoel T; Wolter JM; Schuerman LM Eur J Emerg Med; 2006 Apr; 13(2):67-71. PubMed ID: 16525231 [TBL] [Abstract][Full Text] [Related]
36. Comparison of antibody titers in eleven- to twelve-year old Japanese school children six years after administration of acellular and whole cell pertussis vaccines combined with diphtheria-tetanus toxoids. Okada K; Ueda K; Morokuma K; Fukushige J; Miyazaki C Pediatr Infect Dis J; 1998 Dec; 17(12):1167-9. PubMed ID: 9877371 [No Abstract] [Full Text] [Related]
37. Pertussis immunization of infants using a new combined DTP-polio vaccine. Drucker J; Schatzmayr H; Grenier B; Ajjan N; Peyron L; Roumiantzeff M Dev Biol Stand; 1985; 61():309-13. PubMed ID: 2872119 [TBL] [Abstract][Full Text] [Related]
38. Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3, and 4 months versus 3, 5, and 9 months of age. Booy R; Aitken SJ; Taylor S; Tudor-Williams G; Macfarlane JA; Moxon ER; Ashworth LA; Mayon-White RT; Griffiths H; Chapel HM Lancet; 1992 Feb; 339(8792):507-10. PubMed ID: 1346876 [TBL] [Abstract][Full Text] [Related]
39. Efficacy of diphtheria and tetanus vaccination in Gaza, Palestine. Al Aswad IH; Shubair ME East Mediterr Health J; 2009; 15(2):285-94. PubMed ID: 19554974 [TBL] [Abstract][Full Text] [Related]
40. [The antidiphtheria and antitetanus immunities of children of the Maritime Territory after the use of adsorbed DTP vaccine and adsorbed DT-m anatoxin]. Zaporzhets TS; Lunika IG; Greben'kova LK; Belogolovkina NA; Makarenkova ID; Besednova NN Zh Mikrobiol Epidemiol Immunobiol; 1999; (2):57-9. PubMed ID: 10356739 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]